- Oragenics rallies on encouraging data supporting potential COVID-19 vaccine
seekingalpha.com Jul 22, 2020 9:19 pm
- Oragenics +13% on advancement of COVID-19 vaccine program
- Oragenics inks deal to advance COVID-19 vaccine
- Oragenics, Inc. Receives Further Validation for Lantibiotic Compound OG716
app.quotemedia.com Jan 28, 2019 9:37 pm
- Oragenics enters the COVID-19 vaccine game; shares up 51% premarket
- Oragenics' AG013 flunks mid-stage study; shares down 50% premarket
- Oragenics files for $50M equity offering
- Oragenics (OGEN) Investor Presentation - Slideshow
- Oragenics up 12% on advancement of oral mucositis candidate
- Oragenics collaborates with FIU to expand lantibiotic pipeline
- Oragenics closes $12.5M equity offering
- Oragenics -13.1% on proposed equity offering
- Oragenics up 23%
- Oragenics reports Q3 results
- Oragenics receives clearance to enroll patients into its Phase 2 trial of AG013 for oral mucositis
- Oragenics adds to rally, up 46%
- Premarket Losers as of 9:05 am (07/13/2018)
- Oragenics prices equity offering; shares down 31% premarket
- Oragenics files for equity offering
- Oragenics' AG013 shows favorable safety profile in mid-stage OM study; shares up 34% premarket
- Oragenics nabs U.S. patent covering Lantibiotics; shares up 33%
- Oragenics readies equity offering
